700P First-in-human dose-escalating study of ABSK043, a novel and oral small-molecule inhibitor of PD-L1, in patients with advanced solid tumors
| Autor: | Cooper, A., Andelkovic, V., Wilkinson, K., Ganju, V., Lundy, J., Hong, M., Airey, S., Meng, L.L., Shen, B., Li, H., Yao, L., Zhang, M., Coward, J. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S487-S487 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|